JP2021525512A5 - - Google Patents
Info
- Publication number
- JP2021525512A5 JP2021525512A5 JP2020566267A JP2020566267A JP2021525512A5 JP 2021525512 A5 JP2021525512 A5 JP 2021525512A5 JP 2020566267 A JP2020566267 A JP 2020566267A JP 2020566267 A JP2020566267 A JP 2020566267A JP 2021525512 A5 JP2021525512 A5 JP 2021525512A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- cdr2
- cdr3
- cdr1
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862678080P | 2018-05-30 | 2018-05-30 | |
| US62/678,080 | 2018-05-30 | ||
| PCT/US2019/034259 WO2019231957A1 (en) | 2018-05-30 | 2019-05-29 | Anti-abeta antibodies and uses thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021525512A JP2021525512A (ja) | 2021-09-27 |
| JP2021525512A5 true JP2021525512A5 (https=) | 2022-05-20 |
| JPWO2019231957A5 JPWO2019231957A5 (https=) | 2022-05-20 |
| JP7210612B2 JP7210612B2 (ja) | 2023-01-23 |
Family
ID=68694402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566267A Active JP7210612B2 (ja) | 2018-05-30 | 2019-05-29 | 抗ａベータ抗体及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11084873B2 (https=) |
| EP (1) | EP3801618A4 (https=) |
| JP (1) | JP7210612B2 (https=) |
| KR (1) | KR102523019B1 (https=) |
| CN (1) | CN112601550B (https=) |
| CA (1) | CA3100896C (https=) |
| TW (1) | TWI721440B (https=) |
| WO (1) | WO2019231957A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018308088B2 (en) | 2017-07-25 | 2025-05-29 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| AU2020214796A1 (en) | 2019-01-30 | 2021-07-29 | Truebinding, Inc. | Anti-Gal3 antibodies and uses thereof |
| WO2021242776A2 (en) | 2020-05-26 | 2021-12-02 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking galectin-3 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201404801YA (en) * | 2005-12-12 | 2014-09-26 | Ac Immune Sa | Monoclonal antibody |
| UA102368C2 (ru) * | 2005-12-12 | 2013-07-10 | Ас Иммуне С.А. | СПЕЦИФИЧЕСКИЕ В ОТНОШЕНИИ β-АМИЛОИДА 1-42 МОНОКЛОНАЛЬНЫЕ АНТИТЕЛА, КОТОРЫЕ ИМЕЮТ ТЕРАПЕВТИЧЕСКИЕ СВОЙСТВА |
| US8003097B2 (en) | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
| WO2009033743A1 (en) * | 2007-09-13 | 2009-03-19 | University Of Zurich Prorektorat Forschung | Monoclonal amyloid beta (abeta)-specific antibody and uses thereof |
| WO2009063970A1 (ja) * | 2007-11-14 | 2009-05-22 | Forerunner Pharma Research Co., Ltd. | 抗gpr49抗体を用いる癌の診断および治療 |
| DK2207568T3 (en) * | 2007-11-16 | 2017-09-18 | Univ Rockefeller | ANTIBODIES SPECIFIC TO THE PROTOFIBRILE FORM OF BETA AMYLOID PROTEIN |
| ES2624835T3 (es) * | 2009-08-06 | 2017-07-17 | Immunas Pharma, Inc. | Anticuerpos que se unen específicamente a los oligómeros A beta y uso de los mismos |
| CN105979962A (zh) | 2012-12-07 | 2016-09-28 | 比奥根国际神经科学公司 | 使用抗Aβ抗体减少脑淀粉样蛋白斑块的方法 |
| US9879076B2 (en) * | 2013-03-15 | 2018-01-30 | Ramot At Tel Aviv University Ltd. | Methods and compositions with immune therapy for treatment of dementia |
| BR112016024214B8 (pt) * | 2014-04-18 | 2023-12-26 | Univ New York State Res Found | Anticorpo monoclonal parcialmente humanizado, composição farmacêutica e uso de um anticorpo monoclonal |
| US10772969B2 (en) * | 2015-11-09 | 2020-09-15 | The University Of British Columbia | N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto |
| DK3430397T3 (da) * | 2016-03-14 | 2022-05-02 | Biogen Int Neuroscience Gmbh | Antistofafhængig cellemedieret fagocytoseassay til pålidelig måling af optagelse af aggregerede proteiner |
-
2019
- 2019-05-29 KR KR1020207034600A patent/KR102523019B1/ko active Active
- 2019-05-29 CA CA3100896A patent/CA3100896C/en active Active
- 2019-05-29 EP EP19811193.2A patent/EP3801618A4/en active Pending
- 2019-05-29 WO PCT/US2019/034259 patent/WO2019231957A1/en not_active Ceased
- 2019-05-29 CN CN201980036565.6A patent/CN112601550B/zh active Active
- 2019-05-29 JP JP2020566267A patent/JP7210612B2/ja active Active
- 2019-05-30 US US16/426,585 patent/US11084873B2/en active Active
- 2019-05-30 TW TW108118733A patent/TWI721440B/zh active